RGC
#1808
Regencell Bioscience Holdings Limited - Ordinary Shares
5.4 4 USD
-0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.45%
Variación mensual
-8.88%
Variación en los últimos 6 meses
-78.24%
Cambio anual
-63.44%
Cierres anteriores
5.5 2
Open
5.5 0
Mínimo
5.4 4
Máximo
5.5 5
Volumen
5
Financials
- Market Capitalization 2.69 B
- Employee 10
- Founded 2014
- CEO N/A
- Website www.regencellbioscience.com
- Headquarter Cayman Islands
- FIGI UNKNOWN
- Industry Fabricantes de medicamentos — especializados y genéricos
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-23.67
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1273 |  AMRX Amneal Pharmaceuticals, Inc. - Class A Common Stock | 17.76 USD | -1.39% | -1.66% | -6.03% | +68.34% | 5.67 B USD | ||
| 1497 |  INDV Indivior Pharmaceuticals, Inc. - Common Stock | 35.09 USD | -0.59% | -6.70% | -15.00% | +4.43% | 4.14 B USD | ||
| 1840 |  SUPN Supernus Pharmaceuticals, Inc. - Common Stock | 44.19 USD | -1.54% | -5.74% | -6.81% | -18.17% | 2.57 B USD | ||
| 1876 |  PBH Prestige Consumer Healthcare Inc. Common Stock | 52.29 USD | +2.15% | +3.30% | +1.55% | -22.51% | 2.48 B USD |